Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
Clinical trial NCT00351221 · TERMINATED
Trial details
- NCT number
- NCT00351221
- Sponsor
- Insmed Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.